Risk Assessment Among Prostate Cancer Patients Receiving Primary Androgen Deprivation Therapy

Lignende værker

• Evaluation of primary androgen deprivation therapy in prostate cancer patients using the J-CAPRA risk score
  af: Akaza, Hideyuki, et al.
  Udgivet: (2013)
• Comparative risk-adjusted mortality outcomes following primary surgery, radiation therapy, or androgen deprivation therapy for localized prostate cancer
  af: Cooperberg, Matthew R., et al.
  Udgivet: (2010)
• Background factors and short-term health-related quality of life in patients who initially underwent radical prostatectomy or androgen deprivation therapy for localized prostate cancer in a Japanese prospective observational study (J-CaP Innovative Study-1)
  af: Satoru Ueno, et al.
  Udgivet: (2018-03-01)
• Background factors and short-term health-related quality of life in patients who initially underwent radical prostatectomy or androgen deprivation therapy for localized prostate cancer in a Japanese prospective observational study (J-CaP Innovative Study-1)
  af: Ueno, Satoru, et al.
  Udgivet: (2018)
• Combined androgen blockade achieved better oncological outcome in androgen deprivation therapy for prostate cancer: Analysis of community‐based multi‐institutional database across Japan using propensity score matching
  af: Onozawa, Mizuki, et al.
  Udgivet: (2018)